Samsung Biologics to Purchase Land for Second Bio Campus
The Contract Pharma website reported that Samsung Biologics, a contract development and manufacturing organization, has signed a land purchase agreement with the Incheon Free Economic Zone on to support the build out of its second Bio Campus. Bio Campus II is designed to support Samsung Biologics’ further expansion of large-scale manufacturing capacity as well as host a multi-modal plant and an open innovation facility.
Click here to read the full article.